Role of the bone marrow microenvironment in multiple myeloma: Impact of niches on drug resistance mechanisms
Authors:
- 22 May 2025
- journal article
- review article
- Published by Elsevier in Seminars in Diagnostic Pathology
- Vol. 42 (4) , 150916
Abstract
No abstract availableKeywords
Funding Information
- Health Commission of Henan Province (222102310101, 242102311116)
This publication has 242 references indexed in Scilit:
- Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2024
- Regulation of miRNA expression by α4β1 integrin‐dependent multiple myeloma cell adhesioneJHaem, 2023
- Blockade of SDF‐1/CXCR4 reduces adhesion‐mediated chemoresistance of multiple myeloma cells via interacting with interleukin‐6Journal of Cellular Physiology, 2019
- Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myelomaJournal of Cellular Physiology, 2018
- Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma developmentThe Journal of Pathology, 2016
- Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppressionThe Journal of Pathology, 2016
- From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammationThe Journal of Pathology, 2012
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Abnormalities of bone marrow mesenchymal cells in multiple myeloma patientsCancer, 2001
- Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA‐1, VLA‐4, LAM‐1, and CD44American Journal of Hematology, 1995